ARK Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.7M | Sell |
24,063
-2,281
| -9% | -$1.02M | 0.08% | 96 |
|
|
2025
Q1 | $12.8M | Buy |
26,344
+994
| +4% | +$482K | 0.13% | 80 |
|
|
2024
Q4 | $10.2M | Sell |
25,350
-25,749
| -50% | -$10.4M | 0.09% | 93 |
|
|
2024
Q3 | $23.8M | Sell |
51,099
-24,365
| -32% | -$11.3M | 0.22% | 60 |
|
|
2024
Q2 | $35.4M | Sell |
75,464
-14,640
| -16% | -$6.86M | 0.31% | 49 |
|
|
2024
Q1 | $37.7M | Sell |
90,104
-34,093
| -27% | -$14.3M | 0.26% | 58 |
|
|
2023
Q4 | $50.5M | Buy |
124,197
+8,866
| +8% | +$3.61M | 0.3% | 46 |
|
|
2023
Q3 | $40.1M | Sell |
115,331
-340
| -0.3% | -$118K | 0.31% | 46 |
|
|
2023
Q2 | $40.7M | Sell |
115,671
-4,838
| -4% | -$1.7M | 0.27% | 45 |
|
|
2023
Q1 | $38M | Sell |
120,509
-1,688
| -1% | -$532K | 0.26% | 47 |
|
|
2022
Q4 | $35.3M | Sell |
122,197
-35,248
| -22% | -$10.2M | 0.31% | 47 |
|
|
2022
Q3 | $45.6M | Sell |
157,445
-208,077
| -57% | -$60.2M | 0.32% | 49 |
|
|
2022
Q2 | $98.2M | Sell |
365,522
-56,253
| -13% | -$15.1M | 0.58% | 36 |
|
|
2022
Q1 | $110M | Sell |
421,775
-507,016
| -55% | -$132M | 0.46% | 39 |
|
|
2021
Q4 | $204M | Sell |
928,791
-780,960
| -46% | -$171M | 0.62% | 36 |
|
|
2021
Q3 | $310M | Sell |
1,709,751
-64,315
| -4% | -$11.7M | 0.74% | 33 |
|
|
2021
Q2 | $358M | Buy |
1,774,066
+55,020
| +3% | +$11.1M | 0.67% | 42 |
|
|
2021
Q1 | $369M | Buy |
1,719,046
+902,852
| +111% | +$194M | 0.73% | 42 |
|
|
2020
Q4 | $193M | Buy |
816,194
+718,842
| +738% | +$170M | 0.51% | 52 |
|
|
2020
Q3 | $26.5M | Buy |
+97,352
| New | +$26.5M | 0.16% | 71 |
|